Darunavir and cobicistat

(Prezcobix®)

Prezcobix®

Drug updated on 1/3/2024

Dosage FormTablet (oral; darunavir/cobicistat 800 mg/150 mg)
Drug ClassMultiple
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For the treatment of HIV-1 infection in treatment-naïve and treatment-experienced adults and pediatric patients weighing at least 40 kg with no darunavir resistanceassociated substitutions (V11I, V32I, L33F, I47V, I50V, I54L, I54M, T74P, L76V, I84V, L89V).